intellim Corporation
Celebrate the 15th anniversary

Accelerating Global Drug Development

We use cookies to ensure that we give you the best experience on our website. It will mean you have agreed with we would get cookies when you continue to see this website.


Our experienced and educated CRAs conduct your clinical study with absolute accuracy, without a hindrance.

intellim can introduce appropriate medical institutions and investigators because we have broad network in Asia for you.

intellim provides strong support from the early stage of drug development to application for approvals as well as post-marketing procedure.

intellim establishes a development support system for practicalapplication of regenerative medicine, including regulatory affairs'consultation, clinical trials, manufacturing, and coordination with KOLs.

intellim consolidates a sequence of operation including Data Capturing, Data Management, Statistical Analysis and Documentation to provide high quality data for you.

intellim provides Regulatory related service for pharmaceuticals and medical devices, medical writing services, various survey services and consulting services for you.

intellim provides Pharmacovigillance services and service for compiling and analyzing the data from Treatment Outcome Study after post marketing.

Our Quality Assurance Team which is independent from Clinical Development Division is involved in GCP Audit. They provide audit services and consulting services for improvements after self-inspection.

intellim provides the Induction Training for CRAs and Oncology Specific Basic and Advanced Training for your staff members.

intellim takes a responsibility as a sponsor for your clinical trials even if you don't have your office in Japan.